MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp (a) inhibitor from China's Jiangsu Hengrui ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an ...

The FDA review – which is due to be completed by 28th September – revolves around the results of the HERCULES trial which ...

President Donald Trump has nominated another candidate to lead the CDC – acting director Susan Monarez – after withdrawing ...

The complaint filed in a Seattle court alleges that Genmab, its subsidiary ProfoundBio that was acquired last year, and ...

To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to use deidentified, population-level electronic health data from the NHS ...

The future of pharmaceutical investment lies in the convergence of ESG principles with a strong emphasis on positive social ...

The team from Massachusetts Institute of Technology (MIT) have suggested that the technology could be useful for applications ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet ...

Augustine Therapeutics has raised €78 million ($85 million) in first-round funding for a pipeline headed by a candidate for ...

At the show, Synchron demonstrated how its Stentrode BCI, a stent-like device implanted via the neck into blood vessels near ...

Novo Nordisk already has a fairly well-stocked pipeline of candidates, but one of its near-term hopes – CagriSema, which ...